Psychometric Validation of the Overall Symptom Severity Score for Chronic Rhinosinusitis
Open Access
- 21 April 2026
- journal article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 174 (6) , 1450-1456
Abstract
Objective: Overall symptom severity (OSS) is a global metric of chronic rhinosinusitis (CRS) symptom severity. We sought to establish psychometric validity for the OSS, which has not been previously demonstrated in the literature. Study Design: Prospective, observational. Setting: Academic medical center. Methods: Adult patients with CRS (N = 647) recruited and completed an OSS score (measured using a visual analog scale [VAS]), 22‐item Sinonasal Outcome Test (SNOT‐22), and 5‐level EuroQol (EQ‐5D) questionnaires. A subset of participants completed these questionnaires at a second time point to establish test‐retest reliability (N = 65) and responsiveness to change (N = 225). Psychometric validation was performed by establishing criterion validity, test‐retest reliability, and responsiveness in these CRS patients. Results: The OSS score was significantly correlated with SNOT‐22 ( r = 0.73, 95% CI: 0.69‐0.76, P < .001) and EQ‐5D VAS scores ( r = −0.39, 95% CI: −0.46 to −0.33, P < .001) at enrollment, demonstrating criterion validity. For the subset of participants who completed the OSS at a second time point ranging between 31 and 143 days later, the change in OSS was correlated with changes in SNOT‐22 score ( r = 0.72, 95% CI: 0.65‐0.78, P < .001), and EQ‐5D VAS ( r = −0.30, 95% CI: −0.42 to −0.18, P < .001). The OSS score also demonstrated excellent test‐retest reliability ( r = 0.92, 95% CI: 0.87‐0.95, P < .001). Using a distribution‐based and four different anchor‐based calculations, the minimal clinically important difference (MCID) for improvement and worsening for the OSS score was determined as ≥1.6 (or >1.5). Conclusion: The OSS score is a psychometrically valid measure of CRS symptom severity, with excellent criterion validity, test‐retest reliability, and responsiveness. The MCIDs for improvement and worsening are proposed to be ≥1.6 (or >1.5).Keywords
This publication has 23 references indexed in Scilit:
- Patient‐reported disease control versus overall symptom severity as global metrics of chronic rhinosinusitis disease statusInternational Forum of Allergy & Rhinology, 2024
- Recommendations to address respondent burden associated with patient-reported outcome assessmentNature Medicine, 2024
- Patient perspectives on recall period and response options in patient‐reported outcome measures for chronic rhinosinusitis symptomatology: An international multi‐centered studyInternational Forum of Allergy & Rhinology, 2023
- Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collectionNature Communications, 2022
- COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measuresQuality of Life Research, 2021
- A contemporary analysis of clinical and demographic factors of chronic rhinosinusitis patients and their association with disease severityIrish Journal of Medical Science (1971 -), 2018
- Patient-reported outcome measures for adult chronic rhinosinusitis: A systematic review and quality assessmentJournal of Allergy and Clinical Immunology, 2015
- The EQ‐5D: A new tool for studying clinical outcomes in chronic rhinosinusitisThe Laryngoscope, 2014
- Modification of the lund‐kennedy endoscopic scoring system improves its reliability and correlation with patient‐reported outcome measuresThe Laryngoscope, 2014
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990